China Life Insurance (Overseas) Company Analysis

Company Overview

China Life Insurance (Overseas) Company Limited is a major insurance provider operating primarily in Hong Kong, with additional presence in Macau, Singapore, and Indonesia. As a subsidiary of China Life Insurance Company Limited (2628.HK), it benefits from the financial strength and reputation of one of China's largest insurance groups.

The company has been operating in Hong Kong for 40 years and maintains a significant market presence. It ranked 59th in the 2024 Fortune Global 500 list, marking its 22nd consecutive year on this prestigious ranking.

Business Model

China Life (Overseas) offers a comprehensive suite of insurance and financial services products targeting both individual and corporate customers. Their business model centers on:

Collection of insurance premiums across multiple product lines
Investment of premium reserves to generate returns
Fee-based services including wealth management and administration
One-stop medical service platforms (MediPlus)
Mandatory Provident Fund (MPF) and retirement planning services

Financial Performance Highlights

Revenue (TTM)

¥302.92B

Net Income

¥106.94B

Profit Margin

34.01%

Return on Equity

25.37%

P/E Ratio

3.20

Dividend Yield

7.71%

1-Year Return

45.10%

Market Cap

¥890.39B

Product Portfolio

Savings Insurance

Medical Protection

Life Insurance

Retirement Plans

Critical Illness Coverage

Accident Insurance

MPF Schemes

ORSO Schemes

Employee Benefits

Juvenile Protection

Financial Analysis

Based on the financial data provided, China Life Insurance appears to be in a strong financial position:

Balance Sheet Strength: The company has total assets of ¥6.77 trillion as of December 31, 2024, with a book value per share of approximately ¥18.03.
Cash Flow Generation: Operating cash flow of ¥378.8 billion (TTM) demonstrates strong operational performance.
Valuation Metrics: Trading at 3.2x earnings and 0.67x book value, the stock appears potentially undervalued compared to industry averages.
Growth Outlook: Analyst consensus suggests EPS growth will stabilize in the coming years, with a projected 3.57% growth for next year.
Leverage: The debt-to-equity ratio of 38.53% indicates a conservative capital structure.

Investment Considerations

Strengths

Strong financial position with high profit margins
Diversified product portfolio across multiple insurance segments
Attractive dividend yield of 7.71%
Established brand with 40 years of operation in Hong Kong
Part of a Fortune Global 500 company with international presence

Challenges & Risks

Regulatory changes in insurance and financial services sectors
Economic slowdown could impact investment returns
Competition in the premium insurance market
Declining quarterly earnings growth (-81.50% YoY)
Political and economic factors affecting Hong Kong and China markets

Data sources: China Life (Overseas) website and financial statements as of April 2025.